Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at BIO 2024

2024-05-07
|
Page View:

1.png

BIO 2024
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe.

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop R&D services for pharmaceutical enterprises and scientific research institutions around the world. Based on the key requirements of drug R&D, we focus on meeting the demand for innovation and development. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry. As of April 2024, Medicilon has proudly served over 2000 clients worldwide, contributing to the successful approval of over 400 IND applications in China and over 70 INDs overseas, demonstrating our commitment to providing high-quality services and supporting the global advancement of pharmaceutical development.

Medicilon is excited to attend and exhibit at the conference. Dr. Chunlin ChenFounder&CEO of Medicilon USA Corp. and Dr. Qingcong Lin, President of Medicilon USA Corp., will be available at the conference. We look forward to greeting you in San Diego!

Date: June 3-6, 2024
Location: San Diego Convention Center, California

Medicilon Booth #5719-11

Dr.Chen-and-Dr.Lin.png

Meet with Medicilon
Subject丨BIO 2024

Share:
Return
Relevant newsRelevant news